Description

Liptamed-M is a combination oral prescription medication designed for the management of Type 2 diabetes. Each box contains 14 tablets, formulated with a dual-action strength of 500mg Metformin Hydrochloride and 50mg Sitagliptin. These two active ingredients work synergistically to help lower and maintain healthy blood sugar levels. Metformin works primarily by improving insulin sensitivity and reducing glucose production in the liver, while Sitagliptin helps the body increase insulin secretion when blood sugar levels are high. Manufactured by Medpharm Research Ltd, this medication is typically used alongside a healthy diet and exercise regimen to improve glycemic control.